Relevant issues to biossimilars licensing

When the patent of a drug expires, low cost generics may be introduced in market. Trial results that demonstrate the safety and efficacy of the reference product can be extrapolated to the generic, simplifying the approval process. This paradigm cannot be applied to biopharmaceutical products, large...

Full description

Saved in:
Bibliographic Details
Published inRevista brasileira de epidemiologia Vol. 15; no. 4; p. 748
Main Authors Peres, Beatriz Serrapio, Padilha, Gabriela, Quental, Cristiane
Format Journal Article
LanguageEnglish
Published Brazil 01.12.2012
Subjects
Online AccessGet full text

Cover

Loading…